Influence of different dietary salts on the cardiovascular and renal effects of moxonidine in spontaneously hypertensive rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 356, Issue 1, 1997, Pages 107-114

  Mervaala, Eero M A ^a   Malmberg, Lena ^a   Teräväinen, Terttu Liisa ^a,b   Lähteenmäki, Tuula ^a   Karjala, Kirsi ^a   Paakkari, Ilari ^a   Pörsti, Ilkka ^c   Mest, Hans Jürgen ^d   Vapaatalo, Heikki ^a   Karppanen, Heikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d BEIERSDORF AG   (Germany)

Author keywords

Aldosterone; Arterial responses; Left ventricular hypertrophy; Mineral salt; Proteinuria; Renin; Sodium chloride; Spontaneously hypertensive rat

Indexed keywords

ACETYLCHOLINE; ALDOSTERONE; MOXONIDINE; NITROPRUSSIDE SODIUM; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PROTEINURIA; RAT; SALT INTAKE; SODIUM EXCRETION; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION;

ALDOSTERONE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; DRINKING; HEART RATE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; IMIDAZOLES; INSULIN; MALE; MESENTERIC ARTERIES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; ORGAN SIZE; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; RENIN; SALTS; SODIUM CHLORIDE, DIETARY;

EID: 8544251254     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005017     Document Type: Article

References (39)

1. Allan DR, Penner SB, Smyth DD (1993) Renal imidazoline preferring sites and solute excretion in the rat. Br J Pharmacol 108:870-875
2. Amann K, Greber D, Gharehbaghi H, Wiest G, Lange B, Ganten U, Mattfeldt T, Mall G (1991) Effects of nifedipine and moxonidine on cardiac structure in spontaneously hypertensive rats. Stereological studies on myocytes, capillaries, arteries, and cardiac interstitium. Am J Hypertens 5:76-83
3. Aoki K, Yamori Y, Ooshima A, Okamoto K (1972) Effects of high or low sodium intake in spontaneously hypertensive rats. Jpn Circ J 36:539-545
4. Armah BI, Hofferber E, Stenzel W (1988) General pharmacology of the novel centrally acting antihypertensive agent moxonidine. Arzneimittelforschung/Drug Res 38:1426-1434
5. 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats. J Pharmacol Exp Ther 273:1162-1171
6. Chan KS, Sannajust F, Head GA (1996) Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits. J Pharmacol Exp Ther 276:411-420
7. Chrisp P, Faulds D (1992) Moxonidine. A review of its pharamacology, and therapeutic use in essential hypertension. Drugs 44:993-1012
8. DeWardener HE (1990a) The primary role of the kidney and salt intake in the aetiology of essential hypertension: part I. Clin Sci 79:193-200
9. DeWardener HE (1990b) The primary role of the kidney and salt intake in the aetiology of essential hypertension: part II. Clin Sci 79:289-296
10. DiBona GF (1982) The functions of the renal nerves. Rev Physiol Biochem Pharmacol 94:75-181
11. Dietz R, Schömig A, Rascher W, Strasser R, Luth J, Ganten D, Kübier W (1982) Contribution of the sympathetic nervous system to the hypertensive effects of high sodium diet in stroke-prone spontaneously hypertensive rats. Hypertension 4:773-781
12. Elliot P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, Marmot M (1996) Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. BMJ 312:1249-1253
13. Ernsberger P, Elliot HL, Weinmann H-J, Raap A, Haxhiu MA, Hofferber E, Löw-Kröger A, Reid JL, Mest H-J (1993) Moxonidine: a second-generation central antihypertensive agent. Cardiovasc Drug Rev 11:411-431
14. Erwteman TM, Nagelkerke N, Lubsen J, Koster M, Dunning AJ (1984) β-blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial. BMJ 289:406-409
15. Frei M, Kuster L (1994) Moxonidine and hydrochlorothiazide in combination: a synergistic antihypertensive effect. J Cardiovasc Pharmacol 24 [Suppl 1]:S25-S28
16. Fujita T, Sato Y (1992) Role of hypothalamic-renal noradrenergic systems in hypotensive action of potassium. Hypertension 20:466-472
17. Geleijnse J, Witteman J, Bak A, Breeijen J den, Grobbee D (1994) Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. BMJ 309:436-440
18. 1-imidazoline receptors in the rostral ventrolateral medulla. J Cardiovasc Pharmacol 24 [Suppl 1]:S1-S8
19. Irzyniec T, Mall G, Greber D, Ritz E (1992) Beneficial effect of nifedipine and moxonidine on glomerulosclerosis in spontaneously hypertensive rats. A micromorphometry study. Am J Hypertens 5:437-443
20. Kähönen M, Arvola P, Vapaatalo H, Pörsti I (1993) Comparison of cumulative and non-cumulative administration of vasoactive agents in arterial smooth muscle responses in vitro. Pharmacol Toxicol 73:142-145
21. Karppanen H, Tanskanen A, Tuomilehto J, Puska P, Vuori J, Jäntti V, Seppänen ML (1984) Safety and effects of potassium- and magnesium-containing low sodium salt mixtures. J Cardiovasc Pharmacol 6:S236-S243
22. Katori M, Majima M (1996) Pivotal role of renal kallikrein-kinin system in the development of hypertension and approaches to new drugs based on this relationship. Jpn J Pharmacol 70:95-128
23. Koepke J, DiBona G (1985) High sodium intake enhances renal nerve and antinatriuretic responses to stress in spontaneously hypertensive rats. Hypertension 7:357-363
24. Li P, Penner SB, Smyth DD (1994) Attenuated renal response to moxonidine and rilmenidine in one kidney-one clip hypertensive rats. Br J Pharmacol 112:200-206
25. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
26. MacGregor GA, Markandu ND, Singer DR, Cappuccio FP, Shore AC (1987) Moderate sodium restriction with angiotension converting enzyme inhibitor in essential hypertension: a double blind study. BMJ 294:531-534
27. Mervaala EMA, Himberg J-J, Laakso J, Tuomainen P, Karppanen H (1992) Beneficial effects of a potassium- and magnesium-enriched salt alternative. Hypertension 19:535-540
28. Mervaala EMA, Laakso J, Himberg J-J, Karppanen H (1994a) Replacement of regular salt by a novel salt alternative improves the cardiovascular effects of the ACE inhibitor enalapril. Hypertens Res 17:59-69
29. Mervaala EMA, Laakso J, Karppanen H (1994b) Cardiovascular effects of felodipine are not antagonized by dietary salt. Eur J Pharmacol 255:73-79
30. Mervaala EMA, Laakso J, Vapaatalo H, Karppanen H (1994c) Improvement of cardiovascular effects of metoprolol by replacement of common salt with a potassium- and magnesium-enriched salt alternative. Br J Pharmacol 112:640-648
31. Mervaala EMA, Paakkari I, Laakso J, Nevala R, Teräväinen T-L, Fyhrquist F, Vapaatalo H, Karppanen H (1994d) Replacement of salt by a novel potassium- and magnesium-enriched salt alternative improves the cardiovascular effects of ramipril. Br J Pharmacol 111:1189-1197
32. Oparil S, Meng QC, Chen Y-F, Yang R-H, Jin H, Wyss JM (1988) Genetic basis of NaCl-sensitive hypertension. J Cardiovasc Pharmacol 12:S56-S69
33. 1 imidazoline receptor agonist, moxonidine. Br J Pharmacol 112:1089-1094
34. Pörsti I, Arvola P, Wuorela H, Ilkka M, Säynävälammi P, Huhtala H, Metsä-Ketelä T, Vapaatalo H (1990) Effects of a high calcium diet and deoxycorticosterone on vascular smooth muscle responses in spontaneously hypertensive rats. J Hypertens 8:835-841
35. Reaven GM, Chang H (1991) Relationship between blood pressure, plasma insulin and triglyseride concentration, and insulin action in spontaneously hypertensive and Wistar-Kyoto rats. Am J Hypertens 4:34-38
36. Tolins JP, Shultz P (1994) Endogenous nitric oxide determines sensitivity to the pressor effect of salt. Kidney Int 46:230-236
37. 2-adrenoceptors in the cardiovascular effects of moxonidine. Eur J Pharmacol 282-19-28
38. Winer B (1961) The antihypertensive mechanisms of salt depletion induced by hydrochlorothiazide. Circulation 24:788-796
39. Young DB, McCaa RE, Pan Y-J, Guyton AC (1976) The natriuretic and hypotensive effects of potassium. Circ Res 38:84-89